Publications
Β-Amyloid Burden is Not Associated with Cognitive Impairment in Schizophrenia: A Systematic Review.. Am J Geriatr Psychiatry. 24(10):923-39.
.
2016. Using proton magnetic resonance spectroscopic imaging to study glutamatergic alterations in patients with schizophrenia: A systematic review.. Schizophr Res. 210:13-20.
.
2019. Trait impulsivity is not related to post-commissural putamen volumes: A replication study in healthy men.. PLoS One. 13(12):e0209584.
.
2018. Trait impulsiveness is related to smaller post-commissural putamen volumes in males but not females.. Eur J Neurosci. 46(7):2253-2264.
.
2017. Thalamic and striato-pallidal volumes in schizophrenia patients and individuals at risk for psychosis: A multi-atlas segmentation study.. Schizophr Res.
.
2020. A systematic review of neuroimaging and acute cannabis exposure in age-of-risk for psychosis.. Transl Psychiatry. 11(1):217.
.
2021. Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.. Psychiatry Res Neuroimaging. 273:16-24.
.
2018. Seeing the bigger picture: multimodal neuroimaging to investigate neuropsychiatric illnesses.. J Psychiatry Neurosci. 45(3):147-149.
.
2020. The role of maternal immune activation in altering the neurodevelopmental trajectories of offspring: A translational review of neuroimaging studies with implications for autism spectrum disorder and schizophrenia.. Neurosci Biobehav Rev. 104:141-157.
.
2019. The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [(11) C]-raclopride and [(11) C]-(+)-PHNO PET.. Hum Brain Mapp. 38(11):5519-5534.
.
2017. The P300 event-related potential in bipolar disorder: A systematic review and meta-analysis.. J Affect Disord. 256:234-249.
.
2019. Neuroanatomical profiles of treatment-resistance in patients with schizophrenia spectrum disorders.. Prog Neuropsychopharmacol Biol Psychiatry. :109839.
.
2019. Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment.. J Alzheimers Dis. 45(3):907-19.
.
2015. Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment.. J Alzheimers Dis. 49(4):1189-90.
.
2016. Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.. Neuropsychopharmacology.
.
2019. .
2017. Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioning.. Psychoneuroendocrinology. 81:80-87.
.
2017. Interactive effects of age and recent substance use on striatal shape morphology at substance use disorder treatment entry.. Drug Alcohol Depend. :107728.
.
2019. .
2021. Hippocampal subfield volumes across the healthy lifespan and the effects of MR sequence on estimates.. Neuroimage. 233:117931.
.
2021. Hippocampal shape across the healthy lifespan and its relationship with cognition.. Neurobiol Aging. 106:153-168.
.
2021. Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.. J Alzheimers Dis. 58(3):747-762.
.
2017. Glutamatergic neurometabolites and cortical thickness in treatment-resistant schizophrenia: Implications for glutamate-mediated excitotoxicity.. J Psychiatr Res. 124:151-158.
.
2020. Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity.. Neuropsychopharmacology. 41(10):2606-13.
.
2016. Glutamate-mediated excitotoxicity in schizophrenia: a review.. Eur Neuropsychopharmacol. 24(10):1591-605.
.
2014.